David M Aronoff

Systematically Prioritizing Candidates in Genome-Based Drug Repurposing

Judith T. Lewis, Nicole M. Zaleski, Jana K. Shirey-Rice, 2019, Assay and drug development technologies.

A Review of the Medical Weblog, Clinical Correlations

David M Aronoff, Barbara A Bartkowiak, 2010, Clinical Medicine & Research.

Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human Genetics.

Lisa Bastarache, Joshua C Denny, Dan M Roden, 2017, Assay and drug development technologies.

Using What We Already Have: Uncovering New Drug Repurposing Strategies in Existing Omics Data.

Nicole M. Zaleski, Anup P Challa, Robert R Lavieri, 2020, Annual review of pharmacology and toxicology.

When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy Data.

Rebecca N Jerome, Leslie J Crofford, Nicole M. Zaleski, 2017, Assay and drug development technologies.

Epidemiology of Clostridium difficile Infection

David M Aronoff, D. Aronoff, Daryl D Depestel, 2013, Journal of pharmacy practice.

Lipid profiling of polarized human monocyte-derived macrophages.

David M Aronoff, John A McLean, J Rafael Montenegro-Burke, 2016, Prostaglandins & other lipid mediators.